Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-2,710
Closed -$228K – 293
2017
Q3
$228K Buy
+2,710
New +$192K 0.02% 264
2017
Q2
– Sell
-3,078
Closed -$224K – 280
2017
Q1
$224K Buy
+3,078
New +$202K 0.02% 261

Other funds holding ADNT

Dowling & Yahnke's ADNT Position: Q4 2017 in Review

Dowling & Yahnke sold out of Adient (ADNT) in Q4 2017, closing a stake of 2,710 shares — an estimated $228K sold.

Dowling & Yahnke first reported a position in ADNT in Q1 2017 and held it in 2 quarters. The position peaked at $228K in Q3 2017. 450 funds tracked by Wall St. Rank hold ADNT as of Q4 2017.

  • Dowling & Yahnke reported no remaining Adient position as of Q4 2017 after selling out during the quarter.
  • Dowling & Yahnke sold 2,710 Adient shares in Q4 2017, an estimated $228K.
  • Dowling & Yahnke first reported a position in Adient in Q1 2017 and held it in 2 quarters.
  • Dowling & Yahnke's Adient position peaked at $228K in Q3 2017.
  • 450 funds tracked by Wall St. Rank held Adient as of Q4 2017.

Based on Dowling & Yahnke's 13F filing for Q4 2017, filed 2 Feb 2018.